GRAIL, Inc. (GRAL)Healthcare | Diagnostics & Research | Menlo Park, United States | NasdaqGS
138.25 USD
+0.88
(0.641%)
⇧
(Oct. 13, 2026, 10:54 a.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 3:49 a.m. EDT
GRAIL presents a stark dichotomy: a cash-rich, high-growth revenue business currently under siege by litigation. While the stock has rallied nearly fourfold in the past year, trading well above consensus targets, the legal overhang—specifically fraud allegations and a class-action deadline—casts a long shadow over the valuation. The company burns significant operating cash despite holding substantial net assets, and the options market is hedging heavily against downside risk. Until the legal clouds clear and profitability is achieved, the high multiples appear disconnected from the earnings reality. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.151889 |
| MSTL | 0.189874 |
| AutoETS | 0.192042 |
| AutoARIMA | 0.192209 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 18% |
| H-stat | 39.93 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 1.74 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 3.591 |
| Revenue per Share | 4.114 |
| Market Cap | 6,175,106,560 |
| Forward P/E | -16.76 |
| Beta | 2.84 |
| Profit Margins | -236.95% |
| Previous Name | GRAIL, LLC |
| Website | https://grail.com |
As of Oct. 10, 2026, 3:49 a.m. EDT: Speculators are positioning defensively with heavy OTM put volume, suggesting a fear of a sharp correction despite the rally. ATM IV is elevated, indicating uncertainty.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.98253715 |
| Address1 | 1,525 O’Brien Drive |
| All Time High | 166.475 |
| All Time Low | 12.33 |
| Ask | 138.94 |
| Ask Size | 1 |
| Audit Risk | 1 |
| Average Analyst Rating | 2.1 - Buy |
| Average Daily Volume10 Day | 1,204,680 |
| Average Daily Volume3 Month | 949,378 |
| Average Volume | 949,378 |
| Average Volume10Days | 1,204,680 |
| Beta | 2.838 |
| Bid | 97.94 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | 56.926 |
| City | Menlo Park |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 138.25 |
| Current Ratio | 10.949 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 139.1099 |
| Day Low | 135.24 |
| Debt To Equity | 3.591 |
| Display Name | GRAIL |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,785,961,800 |
| Earnings Call Timestamp Start | 1,785,961,800 |
| Earnings Timestamp | 1,785,960,000 |
| Earnings Timestamp End | 1,794,427,200 |
| Earnings Timestamp Start | 1,794,427,200 |
| Ebitda | -378,488,992 |
| Ebitda Margins | -2.29022 |
| Enterprise To Ebitda | -14.176 |
| Enterprise To Revenue | 32.466 |
| Enterprise Value | 5,365,500,416 |
| Eps Current Year | -7.51529 |
| Eps Forward | -8.25022 |
| Eps Trailing Twelve Months | -9.7 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 93.4858 |
| Fifty Day Average Change | 44.7642 |
| Fifty Day Average Change Percent | 0.47883418 |
| Fifty Two Week Change Percent | 98.253716 |
| Fifty Two Week High | 166.475 |
| Fifty Two Week High Change | -28.225006 |
| Fifty Two Week High Change Percent | -0.16954501 |
| Fifty Two Week Low | 41.5 |
| Fifty Two Week Low Change | 96.75 |
| Fifty Two Week Low Change Percent | 2.3313253 |
| Fifty Two Week Range | 41.5 - 166.475 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,718,199,000,000 |
| Float Shares | 34,327,341 |
| Forward Eps | -8.25022 |
| Forward P E | -16.757128 |
| Free Cashflow | -103,579,128 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 910 |
| Fullday Change | 0.8800049 |
| Fullday Change Percent | 0.64060926 |
| Fullday Price | 138.25 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.49707 |
| Gross Profits | 82,147,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.04915 |
| Held Percent Institutions | 0.86288 |
| Implied Shares Outstanding | 44,666,234 |
| Industry | Diagnostics & Research |
| Industry Disp | Diagnostics & Research |
| Industry Key | diagnostics-research |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California. |
| Long Name | GRAIL, Inc. |
| Market | us_market |
| Market Cap | 6,175,106,560 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_321823804 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-10-13 |
| Net Income To Common | -391,587,008 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 4,847,179,713 |
| Number Of Analyst Opinions | 10 |
| Open | 137.64 |
| Operating Cashflow | -294,748,992 |
| Operating Margins | -3.31998 |
| Overall Risk | 7 |
| Phone | 833 694 2553 |
| Prev Name | GRAIL, LLC |
| Previous Close | 137.37 |
| Price Eps Current Year | -18.39583 |
| Price Hint | 2 |
| Price To Book | 2.4285915 |
| Price To Sales Trailing12 Months | 37.36533 |
| Profit Margins | -2.36948 |
| Quick Ratio | 10.55 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.09091 |
| Region | US |
| Regular Market Change | 0.8800049 |
| Regular Market Change Percent | 0.64060926 |
| Regular Market Day High | 139.1099 |
| Regular Market Day Low | 135.24 |
| Regular Market Day Range | 135.24 - 139.1099 |
| Regular Market Open | 137.64 |
| Regular Market Previous Close | 137.37 |
| Regular Market Price | 138.25 |
| Regular Market Time | 1,791,903,264 |
| Regular Market Volume | 101,489 |
| Return On Assets | -0.12031999 |
| Return On Equity | -0.16124001 |
| Revenue Growth | 0.257 |
| Revenue Per Share | 4.114 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 44,666,234 |
| Shares Percent Shares Out | 0.17930001 |
| Shares Short | 8,009,746 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 8,512,679 |
| Short Name | GRAIL, Inc. |
| Short Percent Of Float | 0.1822 |
| Short Ratio | 6.06 |
| Source Interval | 15 |
| State | CA |
| Symbol | GRAL |
| Target High Price | 175.0 |
| Target Low Price | 74.0 |
| Target Mean Price | 122.1 |
| Target Median Price | 120.0 |
| Total Cash | 861,609,024 |
| Total Cash Per Share | 19.29 |
| Total Debt | 91,309,000 |
| Total Revenue | 165,263,008 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -9.7 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 75.1689 |
| Two Hundred Day Average Change | 63.0811 |
| Two Hundred Day Average Change Percent | 0.8391915 |
| Type Disp | Equity |
| Volume | 101,489 |
| Website | https://grail.com |
| Zip | 94,025 |